US Patent 10844371 Antigen binding molecules and methods of use thereof
Patent 10844371 was granted and assigned to Kite Pharma, Inc. on November, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 11 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
108443710
Date of Patent
November 24, 2020
0Patent Application Number
161385420
Date Filed
September 21, 2018
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
108443710
Date of Patent
November 24, 2020
0Patent Application Number
161385420
Date Filed
September 21, 2018
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10844371 Antigen binding molecules and methods of use thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10844371
Date of patent
November 24, 2020
Patent application number
16138542
Date Filed
September 21, 2018
Patent primary examiner
Find more entities like US Patent 10844371 Antigen binding molecules and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
